Parkinson’s disease in China: a forty-year growing track of bedside work

The number and health burden of Parkinson’s disease increase rapidly in China. It is estimated that China will have nearly half of the Parkinson’s disease population in the world in 2030. In this review, we present an overview of epidemiology and health economics status of Parkinson’s disease across...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Gen, Ma, Jianfang, Cui, Shishuang, He, Yixi, Xiao, Qin, Liu, Jun, Chen, Shengdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668186/
https://www.ncbi.nlm.nih.gov/pubmed/31384434
http://dx.doi.org/10.1186/s40035-019-0162-z
Descripción
Sumario:The number and health burden of Parkinson’s disease increase rapidly in China. It is estimated that China will have nearly half of the Parkinson’s disease population in the world in 2030. In this review, we present an overview of epidemiology and health economics status of Parkinson’s disease across China and discuss the risk factors of Parkinson’s disease and related complications. From the view of clinical research, we also discuss the current status of clinical trials, diagnostic biomarkers, treatment of Parkinson’s disease, tertiary network and post-occupation education in Chinese Parkinson’s disease clinics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40035-019-0162-z) contains supplementary material, which is available to authorized users.

Ejemplares similares